Pay in 4 interest-free payments of $5.77 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
It sounds like someone who's really done their research
GLP-1 therapies influence pathways tied to addiction and reward, according to the Endocrine Society A randomized clinical trial published in JAMA Psychiatry found semaglutide reduced alcohol cravings and consumption Users commonly report: Reduced desire to drink Feeling full faster when drinking Less reward from alcohol The data: early, but directionally consistent While long-term industry sales data is still developing, the early signals from clinical studies, observational research, and population polling all point in the same direction: GLP-1 use is associated with lower alcohol consumption for at least some users
.jpg)
Get Started Today As the demand for GLP-1 medications continues to grow, now is the time to explore how a direct-to-consumer prescription program can enhance your service offerings and meet the evolving needs of your patients
Neel Shah and Dr
Shimizu, W
.png)
